MARISSA PITTIUS: Open Payments
NPI 1528638558 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,883 in 119 payments from 19 companies in 2025. Trend: 2023 $1,931 · 2024 $1,543 · 2025 $1,883
Food & beverage: $1,883
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 68 | $727 |
| Lilly USA, LLC | 6 | $309 |
| Biogen, Inc. | 9 | $153 |
| SK Life Science, Inc. | 4 | $88 |
| UCB, Inc. | 5 | $85 |
| PFIZER INC. | 4 | $78 |
| Lundbeck LLC | 4 | $67 |
| Vanda Pharmaceuticals Inc. | 4 | $67 |
| Neurocrine BioSciences, Inc. | 3 | $61 |
| Boston Scientific Corporation | 1 | $47 |
Products named: UBRELVY, QULIPTA, KISUNLA, LEQEMBI, TYSABRI, NURTEC ODT, VYEPTI, PONVORY.
Industry payments across NJ — which companies pay providers there.
